 Gastrointestinal Diseases
"Gastrointestinal Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
| Descriptor ID |
D005767
|
| MeSH Number(s) |
C06.405
|
| Concept/Terms |
Gastrointestinal Diseases- Gastrointestinal Diseases
- Disease, Gastrointestinal
- Diseases, Gastrointestinal
- Gastrointestinal Disease
Functional Gastrointestinal Disorders- Functional Gastrointestinal Disorders
- Disorder, Functional Gastrointestinal
- Disorders, Functional Gastrointestinal
- Functional Gastrointestinal Disorder
- Gastrointestinal Disorder, Functional
- Gastrointestinal Disorders, Functional
|
Below are MeSH descriptors whose meaning is more general than "Gastrointestinal Diseases".
Below are MeSH descriptors whose meaning is more specific than "Gastrointestinal Diseases".
This graph shows the total number of publications written about "Gastrointestinal Diseases" by people in this website by year, and whether "Gastrointestinal Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2010 | 2 | 0 | 2 | | 2013 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Gastrointestinal Diseases" by people in Profiles.
-
Nichols RC, George TJ, Zaiden RA, Awad ZT, Asbun HJ, Huh S, Ho MW, Mendenhall NP, Morris CG, Hoppe BS. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol. 2013 Apr; 52(3):498-505.
-
Sethi S, Garey KW, Arora V, Ghantoji S, Rowan P, Smolensky M, DuPont HL. Increased rate of irritable bowel syndrome and functional gastrointestinal disorders after Clostridium difficile infection. J Hosp Infect. 2011 Feb; 77(2):172-3.
-
Cottreau J, Baker SF, DuPont HL, Garey KW. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Rev Anti Infect Ther. 2010 Jul; 8(7):747-60.
-
van Randen A, Laméris W, Nio CY, Spijkerboer AM, Meier MA, Tutein Nolthenius C, Smithuis F, Bossuyt PM, Boermeester MA, Stoker J. Inter-observer agreement for abdominal CT in unselected patients with acute abdominal pain. Eur Radiol. 2009 Jun; 19(6):1394-407.
-
Szilagyi A, Ghali MP. Pharmacological therapy of vascular malformations of the gastrointestinal tract. Can J Gastroenterol. 2006 Mar; 20(3):171-8.
-
Gerard L, Garey KW, DuPont HL. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections. Expert Rev Anti Infect Ther. 2005 Apr; 3(2):201-11.
-
Bucci LR, Hickson JF, Wolinsky I, Pivarnik JM. Ornithine supplementation and insulin release in bodybuilders. Int J Sport Nutr. 1992 Sep; 2(3):287-91.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|